The Europe Ophthalmic Handheld Surgical Instruments Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030).
The aging demographic is a significant driver of the adoption of ophthalmic handheld instruments. With age comes an increased incidence of eye conditions, particularly cataracts and age-related macular degeneration, necessitating surgical interventions where these instruments play a pivotal role. Geriatric patients often present unique challenges in terms of health conditions, frailty, and comorbidities. Ophthalmic handheld instruments tailored for precision are crucial in addressing the specific needs of geriatric patients, ensuring optimal surgical outcomes, and minimizing postoperative complications.
Ophthalmic surgeries are witnessing a paradigm shift with the integration of advanced technologies into handheld instruments. Robotics, microsurgery, and imaging technologies enhance surgical precision, contributing to improved outcomes and expanding the applicability of these instruments across various procedures. The integration of advanced technologies allows for the customization of handheld instruments based on the specific requirements of different ophthalmic procedures. Surgeons can now choose instruments optimized for cataract surgery, glaucoma interventions, or retinal surgeries, aligning with the nuances of each procedure.
The UK, like many developed nations, has many people with the risk of developing various eye diseases, such as cataracts, glaucoma, and age-related macular degeneration. This contributes to a higher prevalence of eye conditions, driving the demand for ophthalmic surgeries and associated instruments. As per the data released in 2021 by the National Health Service of the United Kingdom, over 2 million individuals with visual impairments reside in the United Kingdom. Approximately 340,000 of these individuals are certified as blind or partially sighted. Thus, Europe's growing number of eye diseases will boost the demand for these instruments in the coming years.
The Germany market dominated the Europe Ophthalmic Handheld Surgical Instruments Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $211.2 Million by 2030. The UK market is exhibiting a CAGR of 3.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.2% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on Product, the market is segmented into Ophthalmic Knives, Forceps, Scissor, Chopper, Rapid Immunotherapies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Ophthalmic Handheld Surgical Instruments Market will Hit $3.2 Billion by 2030, at a CAGR of 4.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Metall Zug AG (Haag-Streit AG), Surgical Holdings, Ziemer Ophthalmic Systems AG, Topcon Corporation, Carl Zeiss Meditec AG, Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Alcon, Inc., Appasamy Associates Private Limited and INKA Surgical Instruments
By End-use
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
